Rajiv Gandhi Cancer Institute In India

What Rajiv Gandhi Cancer Institute In India does

Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) is a Delhi-based, not-for-profit comprehensive cancer hospital operated by the Indraprastha Cancer Society and Research Centre and established in 1996. It operates two campuses in the Delhi NCR region — the main campus in Rohini (D-18, Sector-5) and a second campus at Niti Bagh in South Delhi — and runs 20+ cancer sub-specialties under one roof. Its clinical staff base comprises 100+ consultant oncologists, 150 resident doctors, and 650 support staff, and the institute treats roughly 100,000 Indian and foreign patients annually, including a dedicated international patient services line.

RGCIRC delivers multi-modality cancer care across surgical oncology, medical oncology (chemotherapy, immunotherapy, targeted therapy, hormonal therapy), radiation oncology (IMRT, IGRT, SBRT, CyberKnife, brachytherapy), pediatric hematology-oncology, and hematology oncology with bone marrow transplantation (autologous, allogeneic, matched sibling, matched unrelated, haploidentical, and CAR-T cell therapy). The institute has been an early clinical site for India's indigenous SSI Mantra surgical robot in partnership with SSI Innovations, alongside DaVinci robotic platforms, and additionally offers HIPEC, MRI-fusion prostate biopsy, interventional radiology, nuclear medicine (PET-CT), and a Biorepository for cancer research (tissue, viable cells, blood, biofluids, digital pathology, tumour microarrays). It runs fellowship, DNB, BMTR, diploma, and certified training programs and is affiliated with academic partners including St. Jude Children's Research Hospital, Duke University Medical Center, INPHOG, SIOP, IARS, and the National Cancer Grid.

The business model is a professional-services hospital model monetising patient care (diagnostics, inpatient treatment, surgery, BMT), telemedicine consultations, second-opinion services, corporate/insurance reimbursement via Third Party Administrators, and education/training programs; donations are actively solicited via dedicated domestic and international donation portals. Go-to-market is primarily direct-to-consumer (walk-in, self-referral, app/website booking, referral from other providers) with supplementary channel partnerships through insurance TPAs and corporate healthcare plans. Pricing is not publicly disclosed and is quote-based on treatment protocol and room category, ranging from general ward to private suites, with participation in Ayushman Bharat PMJAY-linked reimbursement through National Cancer Grid guidelines.

Name

Rajiv Gandhi Cancer Institute In India

Legal name

Rajiv Gandhi Cancer Institute & Research Centre

Website

https://rgcirc.org

Company type

Private

Founded year

1996

Operating status

Operating

Short description

RGCIRC is a Delhi NCR-based, not-for-profit comprehensive cancer hospital operating two campuses (Rohini and Niti Bagh) since 1996. It treats ~100,000 patients annually across 20+ oncology sub-specialties using surgery, radiation, medical oncology, robotic systems, BMT, CAR-T, and HIPEC, supported by a biorepository and DNB/fellowship training programs.

Ownership category

akta.pro rank

Product category

Cancer Care / Oncology Services

NAICS

General Medical and Surgical Hospitals (622110), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

akta.pro secondary industries

Oncology Telemedicine Platforms (HLALAGAH), Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

Keywords

• Cancer treatment services
• Oncology care
• Radiation therapy
• Bone marrow transplant
• Preventive oncology

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain, Others

Revenue model

1. Patient Care Services: Revenue generated from comprehensive cancer treatment services including diagnostics, surgery, radiation therapy, chemotherapy, immunotherapy, and other medical services provided to patients
2. Telemedicine Services: Remote consultation and follow-up services for patients
3. Second Opinion Services: Pathology and clinical second opinion services for patients and other healthcare providers
4. Corporate/Insurance Services (TPA): Cashless and reimbursement-based services through corporate partnerships and insurance Third Party Administrators
5. Education and Training Programs: Fellowship programs, DNB programs, and training courses for medical professionals

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) is a comprehensive cancer care hospital that provides integrated oncology services across surgical, medical, radiation, and pediatric oncology, along with bone marrow transplantation, preventive oncology, and supportive care. It delivers diagnosis, treatment, and follow-up care for adult and pediatric cancer patients at its two hospital campuses in Delhi (Rohini and Niti Bagh), supported by advanced treatment technologies, telemedicine, and clinical research programs.

Product overview

Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) is a comprehensive cancer care hospital offering integrated oncology services across multiple modalities. The institution operates on a hub-and-spoke model with facilities at Rohini and Niti Bagh in Delhi. RGCIRC provides a full spectrum of cancer treatment services including Surgical Oncology, Medical Oncology, Radiation Oncology, Pediatric Hematology & Oncology, Hematology Oncology & Bone Marrow Transplant (BMT), Preventive Oncology, and supportive care services. The hospital features advanced technology platforms including robotic surgery (Da Vinci and SSI Mantra systems), advanced radiation therapy (CyberKnife, LINACs, IMRT, IGRT, SBRT), nuclear medicine (PET-CT), and comprehensive diagnostic imaging. RGCIRC also operates dedicated research facilities including a Biorepository for cancer research and offers clinical trial access to patients. Digital health services include telemedicine, second opinion consultations, and a patient mobile app (RGCI Care) for appointment booking and report access. The institution operates under the Indraprastha Cancer Society and Research Centre, a not-for-profit organization established in 1996.

Differentiator

Problem solved

Functional benefit

Products and services

• Surgical Oncology Services
• Medical Oncology Services
• Radiation Oncology Services
• Pediatric Hematology & Oncology Services
• Hematology Oncology & Bone Marrow Transplant (BMT)
• Preventive Oncology Services
• Radiology and Interventional Oncology Services
• Nuclear Medicine Services
• Laboratory and Transfusion Services
• Pain, Palliative & Home Care
• Biorepository Services
• Clinical Trials
• Telemedicine Services
• Second Opinion Service
• RGCI Care Patient Mobile App
• Blood & Marrow Stem Cell Transplantation
• Immunotherapy Cancer Treatment
• Interventional Radiology
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
• Robotic Surgery Program

Quantifiable outcome

• 100,000 Indian and foreign patients treated annually
• +2 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• International Anesthesia Research Society (IARS)minorStrategic or Co-development Partner · 1 January 2024RGCIRC anesthesiologist Dr. Shagun Bhatia Shah serves on the International Subcommittee of IARS, being the first Indian to deliver a lecture at IARS oncoanesthesia session in Seattle
• Duke University Medical Center, North Carolina, USAcoreStrategic or Co-development Partner · 1 January 2014Blood and Marrow Transplant division training collaboration enabling knowledge exchange and advanced transplant technique training for RGCIRC pediatric oncology team
• St. Jude Children's Research Hospital, Memphis, USAcoreStrategic or Co-development Partner · 1 January 2012International outreach program in pediatric oncology collaboration through which Dr. Sandeep Jain participated, enabling access to international protocols and research collaboration in childhood cancer treatment
• International PatientscoreOthersDedicated international patient services including assistance with travel arrangements, accommodation, visa support, and language interpretation for patients coming from abroad for treatment at RGCIRC
• Insurance and TPA CompaniescoreChannel Partner/ Reseller/ DistributorCorporate Services (TPA) department facilitates cashless and reimbursement-based healthcare services through partnerships with multiple insurance companies and Third Party Administrators for employee healthcare coverage
• SSI Innovations Group (SSI Mantra Robot)coreTechnology or IntegrationDr. Sarbartha Kumar Pratihar contributed to development and clinical trials of India's indigenous SSI Mantra surgical robot, establishing RGCIRC as an early adopter of this Made in India surgical robotic system
• National Cancer Grid (India)coreStrategic or Co-development PartnerRGCIRC participates in National Cancer Grid guidelines development for Head and Neck Tumors and Bone and Soft Tissue tumors, with guidelines linked to Ayushman Bharat PMJAY for reimbursement
• INPHOG (Indian Pediatric Hematology Oncology Group)coreStrategic or Co-development PartnerDr. Shalini Mishra serves as Country PI for UMBRELLA SIOP RTSG Study and chairs Wilms' Tumor Subcommittee of INPHOG, representing India in international pediatric oncology research collaboration
• SIOP (International Society of Pediatric Oncology)coreStrategic or Co-development PartnerRGCIRC participates in international pediatric oncology studies through SIOP and St. Jude Global Initiative, contributing to ARIA Guide adaptation for India

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Max Institute of Cancer Care: Oncology vertical within Max Healthcare's Delhi NCR network; comparable urban, multi-modality cancer care, advanced radiation technology, and competition for the same NCR patient pool.
• HealthCare Global Enterprises (HCG): Listed specialty oncology hospital chain in India with multiple centers offering comprehensive cancer care including robotic surgery, BMT, and radiation oncology — closest pure-play specialist oncology peer to RGCIRC's scope.
• Apollo Cancer Centre: Network of specialty oncology hospitals under Apollo Hospitals (Chennai, Hyderabad, Delhi, etc.). Multi-modality cancer care with advanced technology and a similar private-sector, fee-for-service model targeting Indian and international patients.
• Tata Memorial Hospital: India's premier government-run specialty cancer hospital based in Mumbai. The closest direct comparator to RGCIRC in scope (comprehensive oncology across surgical, medical, radiation, BMT) and academic/research output.
• Medanta Cancer Institute: Cancer care unit within Medanta – The Medicity (Gurugram, near Delhi NCR). Offers surgical, medical, and radiation oncology across sub-specialties including BMT and robotic surgery.

Broad incumbents

• Fortis Memorial Research Institute: Multi-specialty flagship hospital under Fortis Healthcare in Gurugram with a comprehensive oncology program (medical, surgical, radiation, BMT). Competes with RGCIRC in Delhi NCR catchment but operates a broader portfolio.
• AIIMS (Department of Medical Oncology / IRCH): Government-run tertiary academic center with the Institute Rotary Cancer Hospital (IRCH) offering high-volume cancer care and clinical research. Competes for complex case referrals and trains significant oncology talent.

Emerging players

• Kokilaben Dhirubhai Ambani Hospital: Mumbai-based multi-specialty hospital with a dedicated cancer center offering robotic surgery, radiation, and medical oncology. Comparable advanced-technology private oncology positioning in a competing metro.
• Cytecare Cancer Hospital: Bengaluru-based specialty oncology hospital with a focus on organ-specific cancer care and advanced technology. Overlaps with RGCIRC's comprehensive oncology approach but at smaller, more regional scale.

Regional players

• Mazumdar Shaw Medical Centre (Narayana Health): Bengaluru-based cancer hospital within the Narayana Health network, focused on high-volume, affordable oncology including BMT. Comparable comprehensive-cancer offering but primarily South India focused.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCuf6DDn46SjGjnoCsT1KTxA/feed
• Facebookfacebook.com/rgcirc
• LinkedInlinkedin.com/company/rajiv-gandhi-cancer-institute-research-centre
• Instagraminstagram.com/rgcirc_official

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rajiv Gandhi Cancer Institute In India